Please use this identifier to cite or link to this item: http://hdl.handle.net/10201/67041

Title: Lysophosphatidic acid receptors in cancer pathobiology
Issue Date: 2014
Publisher: F. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de Biología Celular e Histología
Citation: Histology and Histopathology, vol. 29, nº 3 (2014)
ISSN: 1699-5848
0213-3911
Related subjects: CDU::5 - Ciencias puras y naturales::57 - Biología::576 - Biología celular y subcelular. Citología
Keywords: LPA receptor
Cancer
Abstract: Lysophosphatidic acid (LPA) receptors (LPA1 to LPA6) are G protein-coupled transmembrane and mediate a variety of biological responses through the binding of LPA, such as cell proliferation, migration, morphogenesis and differentiation. Previously, high secretion levels of LPA were found in blood and ascites from patients with aggressive ovarian cancer. So far, numerical studies have demonstrated that LPA signaling via LPA receptors contributes to the acquisition of malignant potency by several cancer cells. Moreover, genetic and epigenetic alterations of LPA receptor genes have been detected in cancer cells. Therefore, it is suggested that LPA signaling may be a target molecule for the establishment of chemoprevention agents in clinical cancer approaches. Here, we review the current knowledge for the biological roles of LPA signaling via LPA receptors in the pathogenesis of cancer cells.
Primary author: Tsujiuchi, Toshifumi
Araki, Mutsumi
Hirane, Miku
Dong, Yan
Fukushima, Nobuyuki
URI: http://hdl.handle.net/10201/67041
Document type: info:eu-repo/semantics/article
Number of pages / Extensions: 8
Rights: info:eu-repo/semantics/openAccess
Appears in Collections:Vol.29, nº 3 (2014)

Files in This Item:
File Description SizeFormat 
Tsujiuchi-29-313-321-2014.pdf498,99 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons